| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy
|
Keogh, R. J.
|
|
|
88 |
2 |
p. 307-312
|
artikel
|
| 2 |
Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway
|
Chen, Shucheng
|
|
|
88 |
2 |
p. 323-334
|
artikel
|
| 3 |
Correction to: Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ
|
Zhang, Xian-Ming
|
|
|
88 |
2 |
p. 367-368
|
artikel
|
| 4 |
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1–NRF2 signaling
|
Zeng, Hui
|
|
|
88 |
2 |
p. 223-233
|
artikel
|
| 5 |
Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma
|
Noda, Satoshi
|
|
|
88 |
2 |
p. 281-288
|
artikel
|
| 6 |
Glaucocalyxin A induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS
|
Shi, Fanzhe
|
|
|
88 |
2 |
p. 235-246
|
artikel
|
| 7 |
Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia
|
Youssef, Yomna H.
|
|
|
88 |
2 |
p. 313-321
|
artikel
|
| 8 |
MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism
|
Liu, An
|
|
|
88 |
2 |
p. 343-357
|
artikel
|
| 9 |
NCTR25 fusion facilitates the formation of TRAIL polymers that selectively activate TRAIL receptors with higher potency and efficacy than TRAIL
|
Wang, Yan
|
|
|
88 |
2 |
p. 289-306
|
artikel
|
| 10 |
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study
|
Nielsen, Stine Nygaard
|
|
|
88 |
2 |
p. 271-279
|
artikel
|
| 11 |
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
|
Grechko, Nikolay
|
|
|
88 |
2 |
p. 259-270
|
artikel
|
| 12 |
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors
|
Semrad, Thomas J.
|
|
|
88 |
2 |
p. 335-341
|
artikel
|
| 13 |
Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen
|
Deyme, Laure
|
|
|
88 |
2 |
p. 247-258
|
artikel
|
| 14 |
Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas
|
Schalkwijk, Stein
|
|
|
88 |
2 |
p. 189-202
|
artikel
|
| 15 |
Time-dependent population PK models of single-agent atezolizumab in patients with cancer
|
Marchand, Mathilde
|
|
|
88 |
2 |
p. 211-221
|
artikel
|
| 16 |
Tissue distribution of epirubicin after severe extravasation in humans
|
Nedomansky, Jakob
|
|
|
88 |
2 |
p. 203-209
|
artikel
|
| 17 |
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children’s Oncology Group Study ADVL06B1
|
Skolnik, Jeffrey
|
|
|
88 |
2 |
p. 359-365
|
artikel
|
| 18 |
Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever
|
Wardill, H. R.
|
|
|
88 |
2 |
p. 173-188
|
artikel
|
Tijdschrift beschrijving